| 题名 | Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling |
| 作者 | |
| 通讯作者 | Yan,Chen; Liping,Tong; Di,Chen |
| 发表日期 | 2024-02
|
| DOI | |
| 发表期刊 | |
| ISSN | 2352-4820
|
| 页码 | 101247 |
| 相关链接 | [来源记录] |
| 收录类别 | |
| 语种 | 英语
|
| 学校署名 | 其他
|
| 出版者 | |
| 来源库 | 人工提交
|
| 引用统计 | |
| 成果类型 | 期刊论文 |
| 条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/761212 |
| 专题 | 南方科技大学医学院 |
| 作者单位 | 1.Department of Bone and Joint Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China 2.bResearch Center for Computer-aided Drug Discovery, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055,China 3.Faculty of Pharmaceutical Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China 4.Department of Orthopedic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China 5.Shenzhen Healthemes Biotechnology Co., Ltd., Shenzhen, Guangdong 518071, China 6.School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China |
| 推荐引用方式 GB/T 7714 |
Daofu,Zeng,Muhammad,Umar,Zhenglin,Zhu,et al. Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling[J]. Genes & Diseases,2024:101247.
|
| APA |
Daofu,Zeng.,Muhammad,Umar.,Zhenglin,Zhu.,Haobo,Pan.,William W.,Lu.,...&Di,Chen.(2024).Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling.Genes & Diseases,101247.
|
| MLA |
Daofu,Zeng,et al."Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling".Genes & Diseases (2024):101247.
|
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | 操作 | |
| 173.Development of n（3857KB） | -- | -- | 限制开放 | -- | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
;
修改评论